All News

To view HEALTH PROFESSIONAL NEWS - click here
To view COMMUNITY NEWS - click here

AGITG Trial Updates: August 2020

ASCOLT Low-dose aspirin could play an important role in reducing the recurrence of colorectal cancer. The ASCOLT study is an international phase III trial that aims to discover whether taking a daily 200mg dose of aspirin for three years could help to prevent colorectal cancer returning in people who have already... Read More